<DOC>
	<DOCNO>NCT00550576</DOCNO>
	<brief_summary>Subjects suffer bipolar disorder treat specific medication give inform concent receive intravenously one dose Digoxin antibody ( Fab ) . Their response therapy measure accordingly.Previous medication change A base line serum Endogenous Digitalis-like Compounds ( DLC ) level measure use specific laboratory technique compound measure 6 24 hour Fab therapy . Patients also follow use clinical psychological test</brief_summary>
	<brief_title>Antibodies Digoxin Bipolar Disorder</brief_title>
	<detailed_description>Twenty subject suffer bipolar disorder treat specific medication give inform concent include study . All receive open study one intravenously dose Digoxin antibody ( Fab ) . Their response therapy measure accordingly.Previous medication change A base line serum Endogenous Digitalis-like Compounds ( DLC ) level measure use specific laboratory technique compound measure 6 24 hour Fab therapy . Patients also follow use clinical psychological test</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Admitted patient suffer Bipolar Disorder abillity give inform concent Allergy Digoxin Antibodies Renal Liver function impairment Liver Cirrhosis Asthma Patients Digoxin Digitoxin Patients receive Aldactone therapy Heart AV Block Hypo Hyperkalemia admission Potential Suicidal Behaviour</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Digoxin Antibodies</keyword>
	<keyword>Bipolar Disorder</keyword>
</DOC>